We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLTA.L Regulatory News (FLTA)

  • There is currently no data for FLTA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/NON-RI)

8 Mar 2022 13:29

RNS Number : 0565E
Cenkos Securities PLC
08 March 2022
 

NEW AMENDMENT FORM 8.5 (EPT/NON-RI)

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Cenkos Securities plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Filta Group Holdings plc

 

(c) Name of the party to the offer with which exempt principal trader is connected:

Filta Group Holdings plc

 

(d) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

03 March 2022

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

Franchise Brands plc

 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ord GBP0.10

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

54,474

0.19

-

-

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

TOTAL:

54,474

0.19

-

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ord GBP0.01

Purchases

139,948

150.0

147.0

Ord GBP0.01

Sales

100,474

156.0

147.0

 

 

(b) Cash-settled derivative transaction

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

 

Date of disclosure:

08 March 2022

Contact name:

Carla Brayson

 

Telephone number:

020 7397 8984

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEOUPUMPWUPPGWR
Date   Source Headline
7th May 20218:53 amRNSIssue of Equity
4th May 20217:00 amRNSDirector/PDMR Shareholding
27th Apr 202112:50 pmEQSHardman & Co Research : Hardman & Co Video Event | Filta Group Plc - Investor Forum
20th Apr 20212:55 pmEQSHardman & Co Research: Filta Group (FLTA): Getting back into shape
20th Apr 20217:00 amRNSFinal Results
12th Apr 20217:00 amRNSInvestor Presentation
25th Mar 20219:05 amEQSHardman & Co Research: Filta Group (FLTA): Upbeat outlook
25th Mar 20217:00 amRNSTrading Update
4th Mar 20217:00 amRNSProactive One2One Investor Forum
25th Jan 20212:05 pmRNSSecond Price Monitoring Extn
25th Jan 20212:00 pmRNSPrice Monitoring Extension
25th Jan 20217:00 amRNSTrading Update
11th Nov 20204:40 pmRNSSecond Price Monitoring Extn
11th Nov 20204:35 pmRNSPrice Monitoring Extension
16th Sep 202010:00 amEQSHardman & Co Research: Filta Group (FLTA) FOG is lifting
15th Sep 20207:01 amRNSPrivate Investor Conference Call
15th Sep 20207:00 amRNSInterim Results for 6 months ended 30 June 2020
10th Sep 20207:00 amRNSAppointment of UK Managing Director
4th Sep 20209:05 amRNSSecond Price Monitoring Extn
4th Sep 20209:00 amRNSPrice Monitoring Extension
4th Sep 20207:00 amRNSExclusive deal w/ NHS-owned Support Services Group
16th Jul 20201:30 pmRNSAwards of share options & appreciation rights
15th Jul 20203:15 pmRNSDirector/PDMR Shareholding
14th Jul 202011:42 amRNSResult of AGM
14th Jul 20207:00 amRNSAGM Statement
25th Jun 202010:00 amRNSDirector/PDMR Shareholding
19th Jun 20202:36 pmRNSDirector/PDMR Shareholding
18th Jun 20207:00 amRNSPosting of Annual Report & Notice of AGM
28th May 202011:35 amEQSHardman & Co: Filta Group (FLTA): FY'19 results and COVID-19 update
28th May 20207:00 amRNSFinal Results
27th May 20201:52 pmRNS2019 Results Date and Investor Conference Call
13th May 20204:41 pmRNSSecond Price Monitoring Extn
13th May 20204:35 pmRNSPrice Monitoring Extension
12th May 20202:05 pmRNSSecond Price Monitoring Extn
12th May 20202:00 pmRNSPrice Monitoring Extension
11th May 20202:06 pmRNSSecond Price Monitoring Extn
11th May 20202:00 pmRNSPrice Monitoring Extension
7th May 202011:40 amRNSFurther re specialist COVID-19 sanitising service
7th May 20207:00 amRNSLaunch of specialist COVID-19 sanitising service
4th May 202012:01 pmRNSHolding(s) in Company
14th Apr 20202:00 pmRNSPostponement of 2019 audited results
9th Apr 20207:00 amRNSHolding(s) in Company
23rd Mar 20203:15 pmRNSTrading Update and COVID-19 response
13th Feb 20207:00 amRNSPRE-CLOSE TRADING UPDATE
31st Jan 20202:00 pmRNSDirector/PDMR Shareholding
18th Nov 201911:46 amRNSAwards of share options
5th Nov 201910:05 amEQSHardman & Co Research: Filta Group (FLTA): FY19 trading update
5th Nov 20197:00 amRNSTrading Update
27th Sep 20197:00 amRNSIssue of Equity
9th Sep 20199:40 amEQSHardman & Co Research: Filta Group (FLTA) FY19 interim results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.